Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats

Toshiaki Sendo, Yasufumi Kataoka, Yuri Takeda, Wakako Furuta, Ryozo Oishi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

RATIONALE AND OBJECTIVES. Nitric oxide (NO) regulation of endothelial function is involved in the development of acute lung injury. The role of NO in contrast media-induced increases in pulmonary vascular permeability was investigated in a rat model. METHODS. Nonionic (iohexol) and ionic (ioxaglate) contrast media were intravenously injected at 1.5 mL/min in rats. Pulmonary vascular permeability was evaluated by measuring the amount of Evans blue dye uptake as a quantitative marker of albumin extravasation in lung tissue. RESULTS. Intravenous injections of contrast media at doses of 4 and 6 g I/kg induced a dose-dependent increase in pulmonary vascular permeability. L-Arginine (an NO synthase substrate) and N(G)-nitro-L-arginine (L-NNA) (an NO synthase inhibitor) prevented and aggravated, respectively, the increase in pulmonary vascular permeability induced by the contrast medium. An aggravating action of L-NNA was confirmed by morphological and histological observations, this action being blocked by L-arginine (300 mg/kg) but not by D-arginine. Isosorbide dinitrate (1-20 mg/kg), an NO donor, had a dose-dependent protective effect on ioxaglate-increased vascular permeability. CONCLUSIONS. Our experimental findings suggest that contrast media at high doses produce pulmonary edema by inhibiting endothelial NO production, and nitrovasodilators protect against this adverse effect in rats.

Original languageEnglish
Pages (from-to)472-478
Number of pages7
JournalInvestigative Radiology
Volume35
Issue number8
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Capillary Permeability
Contrast Media
Nitric Oxide
Arginine
Lung
Ioxaglic Acid
Nitric Oxide Synthase
Iohexol
Isosorbide Dinitrate
Evans Blue
Nitric Oxide Donors
Acute Lung Injury
Pulmonary Edema
Intravenous Injections
Albumins
Coloring Agents

Keywords

  • Contrast media
  • Isosorbide dinitrate
  • Nitric oxide
  • Pulmonary edema
  • Vascular permeability

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats. / Sendo, Toshiaki; Kataoka, Yasufumi; Takeda, Yuri; Furuta, Wakako; Oishi, Ryozo.

In: Investigative Radiology, Vol. 35, No. 8, 2000, p. 472-478.

Research output: Contribution to journalArticle

Sendo, Toshiaki ; Kataoka, Yasufumi ; Takeda, Yuri ; Furuta, Wakako ; Oishi, Ryozo. / Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats. In: Investigative Radiology. 2000 ; Vol. 35, No. 8. pp. 472-478.
@article{52b8cedbb1504ae3adc8e94b84bf3c2e,
title = "Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats",
abstract = "RATIONALE AND OBJECTIVES. Nitric oxide (NO) regulation of endothelial function is involved in the development of acute lung injury. The role of NO in contrast media-induced increases in pulmonary vascular permeability was investigated in a rat model. METHODS. Nonionic (iohexol) and ionic (ioxaglate) contrast media were intravenously injected at 1.5 mL/min in rats. Pulmonary vascular permeability was evaluated by measuring the amount of Evans blue dye uptake as a quantitative marker of albumin extravasation in lung tissue. RESULTS. Intravenous injections of contrast media at doses of 4 and 6 g I/kg induced a dose-dependent increase in pulmonary vascular permeability. L-Arginine (an NO synthase substrate) and N(G)-nitro-L-arginine (L-NNA) (an NO synthase inhibitor) prevented and aggravated, respectively, the increase in pulmonary vascular permeability induced by the contrast medium. An aggravating action of L-NNA was confirmed by morphological and histological observations, this action being blocked by L-arginine (300 mg/kg) but not by D-arginine. Isosorbide dinitrate (1-20 mg/kg), an NO donor, had a dose-dependent protective effect on ioxaglate-increased vascular permeability. CONCLUSIONS. Our experimental findings suggest that contrast media at high doses produce pulmonary edema by inhibiting endothelial NO production, and nitrovasodilators protect against this adverse effect in rats.",
keywords = "Contrast media, Isosorbide dinitrate, Nitric oxide, Pulmonary edema, Vascular permeability",
author = "Toshiaki Sendo and Yasufumi Kataoka and Yuri Takeda and Wakako Furuta and Ryozo Oishi",
year = "2000",
doi = "10.1097/00004424-200008000-00003",
language = "English",
volume = "35",
pages = "472--478",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats

AU - Sendo, Toshiaki

AU - Kataoka, Yasufumi

AU - Takeda, Yuri

AU - Furuta, Wakako

AU - Oishi, Ryozo

PY - 2000

Y1 - 2000

N2 - RATIONALE AND OBJECTIVES. Nitric oxide (NO) regulation of endothelial function is involved in the development of acute lung injury. The role of NO in contrast media-induced increases in pulmonary vascular permeability was investigated in a rat model. METHODS. Nonionic (iohexol) and ionic (ioxaglate) contrast media were intravenously injected at 1.5 mL/min in rats. Pulmonary vascular permeability was evaluated by measuring the amount of Evans blue dye uptake as a quantitative marker of albumin extravasation in lung tissue. RESULTS. Intravenous injections of contrast media at doses of 4 and 6 g I/kg induced a dose-dependent increase in pulmonary vascular permeability. L-Arginine (an NO synthase substrate) and N(G)-nitro-L-arginine (L-NNA) (an NO synthase inhibitor) prevented and aggravated, respectively, the increase in pulmonary vascular permeability induced by the contrast medium. An aggravating action of L-NNA was confirmed by morphological and histological observations, this action being blocked by L-arginine (300 mg/kg) but not by D-arginine. Isosorbide dinitrate (1-20 mg/kg), an NO donor, had a dose-dependent protective effect on ioxaglate-increased vascular permeability. CONCLUSIONS. Our experimental findings suggest that contrast media at high doses produce pulmonary edema by inhibiting endothelial NO production, and nitrovasodilators protect against this adverse effect in rats.

AB - RATIONALE AND OBJECTIVES. Nitric oxide (NO) regulation of endothelial function is involved in the development of acute lung injury. The role of NO in contrast media-induced increases in pulmonary vascular permeability was investigated in a rat model. METHODS. Nonionic (iohexol) and ionic (ioxaglate) contrast media were intravenously injected at 1.5 mL/min in rats. Pulmonary vascular permeability was evaluated by measuring the amount of Evans blue dye uptake as a quantitative marker of albumin extravasation in lung tissue. RESULTS. Intravenous injections of contrast media at doses of 4 and 6 g I/kg induced a dose-dependent increase in pulmonary vascular permeability. L-Arginine (an NO synthase substrate) and N(G)-nitro-L-arginine (L-NNA) (an NO synthase inhibitor) prevented and aggravated, respectively, the increase in pulmonary vascular permeability induced by the contrast medium. An aggravating action of L-NNA was confirmed by morphological and histological observations, this action being blocked by L-arginine (300 mg/kg) but not by D-arginine. Isosorbide dinitrate (1-20 mg/kg), an NO donor, had a dose-dependent protective effect on ioxaglate-increased vascular permeability. CONCLUSIONS. Our experimental findings suggest that contrast media at high doses produce pulmonary edema by inhibiting endothelial NO production, and nitrovasodilators protect against this adverse effect in rats.

KW - Contrast media

KW - Isosorbide dinitrate

KW - Nitric oxide

KW - Pulmonary edema

KW - Vascular permeability

UR - http://www.scopus.com/inward/record.url?scp=0033861573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033861573&partnerID=8YFLogxK

U2 - 10.1097/00004424-200008000-00003

DO - 10.1097/00004424-200008000-00003

M3 - Article

C2 - 10946974

AN - SCOPUS:0033861573

VL - 35

SP - 472

EP - 478

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 8

ER -